Nalanda India Equity Fund raises Jyothy Labs stake to 7.61%
- Nalanda India Equity Fund acquired 3,102,384 Jyothy Labs shares on Sept 2, 2026
- Stake rose from 6.76% to 7.61% with total holding at 27,940,830 shares
- Transaction settled on Sept 3, 2026 via exchange mechanism
- No warrants or convertible securities involved in the acquisition
*this image is generated using AI for illustrative purposes only.
Nalanda India Equity Fund Limited increased its stake in Jyothy Laboratories to 7.61% following a recent share acquisition.
The Mauritius-based fund purchased 3,102,384 shares carrying voting rights on the exchange, raising its total holding from 24,838,446 shares (6.76%) to 27,940,830 shares.
Transaction Details
The acquisition was executed through open market transactions on September 2, 2026, with settlement completed on September 3, 2026. The transaction did not involve any warrants, convertible securities, or encumbered shares.
| Metric | Before Acquisition | Acquired | After Acquisition |
|---|---|---|---|
| Shares (voting rights) | 24,838,446 | 3,102,384 | 27,940,830 |
| Stake percentage | 6.76% | 0.85% | 7.61% |
Jyothy Laboratories Limited has an equity share capital of 367,214,511 shares. The disclosure was filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Arshad Goodur, Director at Nalanda India Equity Fund Limited, signed the disclosure form dated September 3, 2026.
Historical Stock Returns for Jyothy Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.00% | -4.30% | -2.69% | -18.43% | -40.39% | +19.10% |
What strategic rationale might drive Nalanda India Equity Fund to increase its stake in Jyothy Laboratories to 7.61%?
How could this increased institutional holding impact Jyothy Laboratories' stock liquidity and price volatility in the near term?
Does this acquisition signal a broader trend of foreign funds increasing exposure to Indian consumer goods stocks amid current market conditions?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
